Buket KOSOVA, Vildan ÇETİNTAŞ BOZOK, Hüseyin AKTUĞ, Şirin DEMİRAY BAKTI, Türker ÇAVUŞOĞLU, Saadet Özen AKARCA, Fatih OLTULU, Altuğ YAVAŞOĞLU

Dysregulation of nitric oxide synthase activity and Bcl-2 and caspase-3 gene expressions in renal tissue of streptozotocin-induced diabetic rats

To evaluate the effects of diabetes on nitric oxide synthase (NOS) activity and on gene expressions of B-cell lymphoma protein 2 (Bcl-2) and caspase-3 in the renal tissues of streptozotocin (STZ)-induced rats. Materials and methods: Twenty rats were analyzed in 2 equally distributed groups of healthy controls and STZ-induced diabetic rats. Rats with blood glucose levels of >=250 mg/dL were considered diabetic. Renal tissue sections were analyzed histomorphologically and immunohistochemically. Gene expressions of caspase-3 and Bcl-2 were evaluated by real-time quantitative polymerase chain reaction. Results: Bcl-2 expression significantly decreased in the diabetic group, both at the gene and protein level. Meanwhile, the expression of caspase-3 increased in the diabetic group, especially in proximal renal tubule cells. However, endothelial NOS (eNOS) protein expression in the glomerular endothelial nuclei was stronger in the control group, and protein expression of inducible NOS (iNOS) increased in the renal medullar area in the diabetic group. Conclusion: According to our results, hyperglycemia inhibits eNOS, leading to reduced nitric oxide production in endothelial cells. Inhibition of eNOS was correlated with glomerular cell loss due to apoptosis. Furthermore, increased expression of iNOS was associated with endothelial dysfunction in STZ-induced diabetic rats. The structure most resistant to diabetes-induced damage was the glomerulus, while the renal medullar and proximal renal tubule cells displayed damage and cicatrization.

Anahtar Kelimeler:

Key words: Diabetes mellitus, iNOS, eNOS, Bcl-2, caspase-3

Dysregulation of nitric oxide synthase activity and Bcl-2 and caspase-3 gene expressions in renal tissue of streptozotocin-induced diabetic rats

Keywords:

Key words: Diabetes mellitus, iNOS, eNOS, Bcl-2, caspase-3,

PDF

___

Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA. Acceleration of type I diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 2000; 49: 708-11.
Keren P, George J, Shaish A, Levkovitz H, Janakovic Z, Afek A et al. Eff ect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-defi cient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes 2000; 49: 1064-9.
Ablamunits V, Quintana F, Reshef T, Elias D, Cohen IR. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway. J Autoimmun 1999; 13: 383-92.
Wong FS, Janeway CA Jr. Insulin-dependent diabetes mellitus and its animal models. Curr Opin Immunol 1999; 11: 643-7.
Sugano M, Yamato H, Hayashi T, Ochiai H, Kakuchi J, Goto S et al. High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy. Nutr Metab Cardiovasc Dis 2006; 16: 477-84.
Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A. Amelioration of vascular dysfunction in diabetic rats by an oral protein kinase beta inhibitor. Science 1996; 272: 728-31.
Veelken R, Hilgers KF, Hartner A, Haas A, Böhmer KP, Sterzel RB. Nitric oxide synthase isoforms and glomerular hyperfi ltration in early diabetic nephropathy. J Am Soc Nephrol 2000; 11: 71-9.
Trachtman H, Futterweit S, Pine E, Mann J, Valderrama E. Chronic diabetic nephropathy: role of inducible nitric oxide synthase. Pediatr Nephrol 2002; 17: 20-9.
Xu R, Morales JA, Muniyappa R, Skafar DF, Ram JL, Sowers JR. IL-1-induced nitric oxide production in rat aortic endothelial cells: inhibition by estradiol in normal and high glucose cultures. Life Sci 1999; 64: 2451-62.
Noh H, Ha H, Yu MR, Kang SW, Choi KH, Han DS et al. High glucose increases inducible NO production in cultured rat mesangial cells. Possible role in fi bronectin production. Nephron 2002; 90: 78-85.
Hohenstein B, Hugo CP, Hausknecht B, Boehmer KP, Riess RH, Schmieder RE. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Nephrol Dial Transplant 2008; 4: 1346-54.
Sharma K, Danoff TM, DePiero A, Ziyadeh FN. Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C. Biochem Biophys Res Commun 1995; 207: 80-8.
Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP et al. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993; 42: 221-32.
Han KH, Lim JM, Kim WY, Kim H, Madsen KM, Kim J. Expression of endothelial nitric oxide synthase in developing rat kidney. Am J Physiol Renal Physiol 2005; 288: 694-702.
De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 2000; 130: 963-74.
Ono H, Ono Y, Takanohashi A, Matsuoka H, Frohlich ED. Apoptosis and glomerular injury aft er prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats. Hypertension 2001; 38: 1300-6.
Busse R, I Fleming. Pulsatile stretch and shear stress: physical stimuli determining the production of endothelium derived relaxing factors. J Vasc Res 1998; 35: 73-84.
Choi KC, Kim NH, An MR, Kang DG, Kim SW, Lee J. Alterations of intrarenal renin-angiotensin and nitric oxide systems in streptozotocin-induced diabetic rats. Kidney Int 1997; 60: S23-7.
Sugimoto H, Shikata K, Matsuda M, Kushiro M, Hayashi Y, Hiragushi K et al. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in aff erent and glomerular endothelial cells is involved in glomerular hyperfi ltration of diabetic nephropathy. Diabetologia 1998; 41: 1426-34.
Keynan S, Hirshberg B, Levin-Iaina N, Wexler ID, Dahan R, Reinhartz E et al. Renal nitric oxide production during the early phase of experimental diabetes mellitus. Kidney Int 2000; 58: 740-7.
Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994; 94: 2105-16.
Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota A. Apoptosis in glomerular sclerosis. Kidney Int 1996; 49: 103-11.